Ecolex Logo
The gateway to
environmental law
Search results » Treaty decision

Decision XIV/5: Global database and assessment to determine appropriate measures to complete the transition from chlorofluorocarbon metered-dose inhalers

Document type
Decision
Reference number
XIV/5
Date
Nov 29, 2002
Source
UNEP, InforMEA
Status
Active
Subject
Waste & hazardous substances, Air & atmosphere
Treaty
Montreal Protocol on Substances that Deplete the Ozone Layer (Sep 16, 1987)
Meeting
Fourteenth Meeting of the Parties
Website
ozone.unep.org
Abstract

The Fourteenth Meeting of the Parties decided in Dec. XIV/5:

Noting that while the transition to chlorofluorocarbon-free (CFC-free) alternative treatments for asthma and chronic obstructive pulmonary disease (COPD) depends largely on non-Article 5(1) Parties adopting effective transition strategies and CFC metered-dose inhaler manufacturers diligently developing, seeking approval for, and launching CFC-free metered-dose inhalers and dry-powder inhalers;

Noting with concern the slow transition to CFC-free metered-dose inhalers in some Parties, and the need for affordable and available alternatives in Parties operating under Article 5(1);

Recognizing the desirability of a more transparent presentation of data to assist Parties in better understanding essential use CFC volumes and gauging progress on, and impediments to, the transition;

  1. To request each Party or regional economic integration organization to submit available information to the Ozone Secretariat by 28 February 2003 and annual updates thereafter the following information concerning inhaler treatments for asthma and COPD that contain CFCs or that do not contain CFCs:
    1. CFC and non-CFC metered-dose inhalers and dry-powder inhalers: sold or distributed within the Party, by active ingredient, brand/manufacturer, and source (import or domestic production);
    2. CFC and non-CFC metered-dose inhalers and dry-powder inhalers: produced within the Party for export to other Parties, by active ingredient, brand/manufacturer, source and importing Party;
    3. Non-CFC metered-dose inhalers and dry-powder inhalers: date approved, authorized for marketing, and/or launched in the territory of the Party;
  2. To request the Technology and Economic Assessment Panel to take into account information submitted pursuant to paragraph 1 and other available information in its annual assessment, and to request the Parties to pay due consideration to this information when reviewing their national transition strategies.